BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pediatric Endocrine Society - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://pedsendo.org
X-WR-CALDESC:Events for Pediatric Endocrine Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230304
DTEND;VALUE=DATE:20230308
DTSTAMP:20220601T200315Z
CREATED:20220601T200315Z
LAST-MODIFIED:20220601T200315Z
UID:21135-1677888000-1678233599@pedsendo.org
SUMMARY:11th International Meeting of Pediatric Endocrinology
DESCRIPTION:
URL:https://pedsendo.org/event/11th-international-meeting-of-pediatric-endocrinology/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230307T160000
DTEND;TZID=America/New_York:20230307T170000
DTSTAMP:20230224T191205Z
CREATED:20220627T152003Z
LAST-MODIFIED:20230224T191205Z
UID:21208-1678204800-1678208400@pedsendo.org
SUMMARY:Adrenal SIG: State of the Art Webinar
DESCRIPTION:CAH Management and Emerging Therapies \nSpeaker: Maria G. Vogiatzi\, MD \nDescription: \n\nDescribe current CAH management with glucocorticoid +/ mineralocorticoid replacement and how they may affect outcomes\, such as obesity\, cardiometabolic risk factors and quality of life.\nDescribe new and emerging therapies\, such as modifying release hydrocortisone\, hydrocortisone microsprinkles\, trials with CRH antagonists\, continuous sc hydrocortisone administration and gene therapy trials.\n\nLearning Objectives: \n\nUnderstand limitations of current glucocorticoid therapy in CAH\nUnderstand new and emerging therapies in CAH\, their stage of development and applications\nUnderstand the applications of the emerging therapies in CAH
URL:https://pedsendo.org/event/adrenal-sig-state-of-the-art-webinar/
END:VEVENT
END:VCALENDAR